CANCER EPIGENOMICS: A REVIEW
Journal Title: Internet Journal of Medical Update - Year 2011, Vol 6, Issue 1
Abstract
Epigenetic inactivation of genes that are crucial for the control of normal cell growth is a hallmark of cancer cells. Epigenetic modifications of the DNA do not alter the nucleotide sequence instead they involve the regulation of gene transcription and DNA methylation. Hypermethylation or histone deacetylation, which is within the promoter of a tumor suppressor gene, leads to the silencing as well as a deletion or a mutation of that gene. Cancer cells often show aberrant methylation and the frequency of aberrations increases is seen with the progression of disease. Hypermethylation events can occur early in tumorogenesis, involving the disruption of pathways that may predispose cells to malignant transformation. Epigenetic modification such as DNA methylation can be exploited for clinical purposes in cancer patients, first using hypermethylation as a molecular biomarker of cancer cells and second, epigenetic changes which are potentially reversible.
Authors and Affiliations
Robby kumar, Nishant Sharan
Charles-Édouard Brown-Séquard: A bicentennial tribute
None
Yoga for carers of addicted patients: a carer’s self-report
Caring for those addicted to drugs and/or alcohol can adversely affect carers and this can manifest as stress, anxiety, depression, insomnia, substance misuse and a range of physical health problems. In most health care...
A rare case of myxedema with cardiac tamponade
None
THE ROLE OF NANOTECHNOLOGY IN MOLECULAR IMAGING BY USING FLUORESCENT QUANTUM DOTS
Giant strides in knowledge about nanoparticles have lead to the development of sophisticated fluorescent quantum dots that have enhanced our understanding of the disease process as well as the healing mechanism following...
Touch Surgery™ - The Operating Room in your Pocket: a Surgical Simulation app Publisher: Touch Surgery Labs, 230 City Road, London, EC1V 2QY, UK Available for Android and iOS
None